资讯

The American Journal of Managed Care6 小时
Updated OVARIO Trial Results Reinforce Niraparib Plus Bevacizumab Maintenance for Advanced ...
Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.